 |
Doug Macron is the editor of GenomeWeb's Gene Silencing News. He covers research and therapeutic applications of RNAi, miRNA, and other gene-silencing technologies. E-mail Doug Macron or follow his GenomeWeb Twitter account at @Genesilencing. |
In Its Third Phase, the RNAi Consortium Looks to ncRNAs, Gene Over-Expression
September 27, 2012
In Its Third Phase, the RNAi Consortium Looks to ncRNAs, Gene Over-Expression
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- People in the News: William Rastetter, Carlo Croce, Tyler Jacks, Phillip Sharp
April 4, 2013 / Gene Silencing News - NIH Awards Four Grants in February to Advance Research in siRNA Delivery, miRNA Function
February 24, 2011 / Gene Silencing News - Tools & Techniques: Quantum Dot-based microRNA Detection; siRNA Delivery to Leukemia Cells; and More
June 20, 2013 / Gene Silencing News - IP Update: Recent Patents, Patent Applications Awarded to Asuragen, Merck, Alnylam, and More
June 20, 2013 / Gene Silencing News - IP Update: Recent Patents, Patent Applications Awarded to Rosetta, Venganza, Alnylam, and More
June 13, 2013 / Gene Silencing News